https://www.selleckchem.com/pr....oducts/leukadherin-1
Men and women living with overactive bladder (OA face many treatment decisions as they progress through the treatment pathway. Decisions to pursue specific therapies are highly preference sensitive and ideal for shared decision making (SDM). The aim of this narrative review is to provide urologists with a practical summary of methods to elicit preferences and facilitate SDM to promote patient-centered care for OAB. We explore OAB as a preference sensitive condition through a review of treatment outcomes and present available dat